Skip to main content
. 2013 Oct 1;170(4):835–846. doi: 10.1111/bph.12318

Figure 5.

Figure 5

IL-4, IL-5 and IL-10 in the BAL and lungs of CTRL (n = 5), OVA sensitized and challenged (OVA; n = 5–6) and OVA sensitized and challenged treated with AVE (OVA + AVE; n = 4–6) groups. *P ≤ 0.05, significantly different from CTRL and #P ≤ 0.05, significantly different from OVA; one-way anova followed by Newman–Keuls post test.